These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30674742)

  • 1. Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells.
    Okamoto M; Soeda T; Asamura A; Tanaka K; Watanabe K; Ikeda T
    J Vet Med Sci; 2019 Mar; 81(3):397-400. PubMed ID: 30674742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of the canine telomerase reverse transcriptase gene and its expression in neoplastic and non-neoplastic cells.
    Yazawa M; Okuda M; Kanaya N; Hong SH; Takahashi T; Ohashi E; Nakagawa T; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
    Am J Vet Res; 2003 Nov; 64(11):1395-400. PubMed ID: 14620776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor-α, progesterone receptor, and c-
    Kabir FML; DeInnocentes P; Agarwal P; Mill CP; Riese Nd DJ; Bird RC
    J Vet Sci; 2017 Jun; 18(2):149-158. PubMed ID: 27515268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of mouse telomerase reverse transcriptase gene promoter and identification of proximal core promoter sequences essential for the expression of transgenes in cancer cells.
    Si SY; Song SJ; Zhang JZ; Liu JL; Liang S; Feng K; Zhao G; Tan XQ
    Oncol Rep; 2011 Aug; 26(2):377-82. PubMed ID: 21567104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor expression in canine transitional cell carcinoma.
    Hanazono K; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Iwano H; Uchide T
    J Vet Med Sci; 2015 Jan; 77(1):1-6. PubMed ID: 25223345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
    Günes C; Wezel F; Southgate J; Bolenz C
    Nat Rev Urol; 2018 Jun; 15(6):386-393. PubMed ID: 29599449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
    Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
    Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
    Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N
    Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
    Cheng L; Davidson DD; Wang M; Lopez-Beltran A; Montironi R; Wang L; Tan PH; MacLennan GT; Williamson SR; Zhang S
    Histopathology; 2016 Jul; 69(1):107-13. PubMed ID: 26679899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
    Borah S; Xi L; Zaug AJ; Powell NM; Dancik GM; Cohen SB; Costello JC; Theodorescu D; Cech TR
    Science; 2015 Feb; 347(6225):1006-10. PubMed ID: 25722414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HIF-1α ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia.
    Okamoto M; Asamura A; Tanaka K; Soeda T; Watanabe K; Mizuguchi H; Ikeda T
    Vet Res Commun; 2016 Dec; 40(3-4):131-139. PubMed ID: 27744530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human and canine TERT promoters function equivalently in human and canine cells.
    Arendt ML; Nasir L; Morgan IM
    Vet Comp Oncol; 2010 Dec; 8(4):310-6. PubMed ID: 21062413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced canine BRCA2 expression levels in mammary gland tumors.
    Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
    BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
    Kumar M; Witt B; Knippschild U; Koch S; Meena JK; Heinlein C; Weise JM; Krepulat F; Kuchenbauer F; Iben S; Rudolph KL; Deppert W; Günes C
    Int J Cancer; 2013 May; 132(9):2032-43. PubMed ID: 23023397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder.
    Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H
    Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.
    Sakai K; Yonezawa T; Yamawaki H; Oyamada T
    J Vet Med Sci; 2015 Oct; 77(10):1319-22. PubMed ID: 25985817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay.
    Panarese S; Brunetti B; Sarli G
    J Vet Diagn Invest; 2006 Jul; 18(4):362-8. PubMed ID: 16921875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgene expression of alpha tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity.
    Xiang J; Munegowda MA; Deng Y
    Cancer Gene Ther; 2009 May; 16(5):430-8. PubMed ID: 19096444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The canine telomerase catalytic subunit (dogTERT): characterisation of the gene promoter and identification of proximal core sequences necessary for specific transcriptional activity in canine telomerase positive cell lines.
    Long S; Argyle DJ; Gault EA; Campbell S; Nasir L
    Gene; 2005 Sep; 358():111-20. PubMed ID: 16051448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
    Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
    Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.